Immunological features in a case of subacute sclerosing panencephalitis treated with transfer factor.
D000293:Adolescent; D000818:Animals; D000914:Antibodies, Viral / Q000032:analysis / Q000134:cerebrospinal fluid; D001853:Bone Marrow / Q000032:analysis; D001854:Bone Marrow Cells; D002556:Cerebrospinal Fluid Proteins; D003208:Concanavalin A / Q000494:pharmacology; D006385:Hemagglutination Inhibition Tests; D006801:Humans; D006968:Hypersensitivity, Delayed; D007106:Immune Sera; D007112:Immunity, Maternally-Acquired; D007070:Immunoglobulin A / Q000134:cerebrospinal fluid; D007128:Immunoglobulin Fragments / Q000032:analysis / Q000134:cerebrospinal fluid; D007074:Immunoglobulin G / Q000032:analysis / Q000134:cerebrospinal fluid; D008214:Lymphocytes / Q000187:drug effects*; D008222:Lymphokines / Q000627:therapeutic use*; D008297:Male; D008934:Mitogens / Q000494:pharmacology; D011817:Rabbits / Q000276:immunology; D012075:Remission, Spontaneous; D013344:Subacute Sclerosing Panencephalitis / Q000097:blood / Q000134:cerebrospinal fluid / Q000276:immunology* / Q000628:therapy; D013997:Time Factors
D000914:Antibodies, Viral; D002556:Cerebrospinal Fluid Proteins; D007106:Immune Sera; D007070:Immunoglobulin A; D007128:Immunoglobulin Fragments; D007074:Immunoglobulin G; D008222:Lymphokines; D008934:Mitogens; D003208:Concanavalin A